Angela Weyand/medschool.umich.edu
Jul 22, 2026, 14:31
What Could Shape the Future of Hemophilia A Care? – Novo Nordisk Medical US
Novo Nordisk Medical US shared a post on X:
“Thank you to everyone who connected with us at ISTH26!
Hear Dr. Angela Weyand discuss her key takeaways from this year’s meeting and what they could mean for the future of hemophilia A care.
Discover ISTH resources from Novo Nordisk.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Jul 22, 2026, 10:35Ifeanyichukwu Ifechidere: We’ve Trained an Entire Generation of Clinicians to Fear The Wrong Thing About HIT
-
Jul 22, 2026, 10:16Ney Carter Borges: Understanding Pathophysiology as the Foundation of Precision Cardiovascular Care
-
Jul 22, 2026, 10:01George Cieutat: Strengthening Connections Across the Bleeding Disorders Community
-
Jul 22, 2026, 09:57Ming Y Lim: Demonstrating the Value of Upfront Emicizumab at ISTH 2026
-
Jul 22, 2026, 09:52Danny Hsu: Get to Do Some Fun Stuff at ISTH 2026
-
Jul 22, 2026, 09:48Nita Radhakrishnan: The People Behind the Science at ISTH 2026
-
Jul 22, 2026, 09:46Clinical Trial Recruitment for the HARP Mother–Baby Study – HARP
-
Jul 22, 2026, 09:41Shaymaa Alhabib: From My First PhD Poster to ISTH 2026
-
Jul 22, 2026, 09:35A Novel Peptide Strategy to Prevent Surface-Triggered Thrombosis – JTH